Drug Type Small molecule drug |
Synonyms Neosaldina |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC36H56N8NaO14S |
InChIKeyRNWWIQRQNMHIFA-AXNKDMQCSA-N |
CAS Registry1801585-49-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ulcer | Phase 2 | CA | 31 Jan 2004 | |
Varicose Ulcer | Phase 2 | CA | 31 Jan 2004 | |
Wounds and Injuries | Phase 2 | CA | 31 Jan 2004 | |
Brain Injuries | Phase 2 | US | - | |
Cognitive Dysfunction | Phase 2 | US | - | |
Dementia, Vascular | Phase 2 | US | - |